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ABSTRACT 23 
Two defective bovine parainfluenza virus type 3 (BPIV3) strains were generated, one 24 
lacking the membrane (M) protein gene and expressing EGFP (∆M-EGFP) and the 25 
other lacking the fusion (F) protein gene and expressing mStrawberry (∆F-mSB), by 26 
supplying deficient proteins in trans. When Madin-Darby bovine kidney (MDBK) cells 27 
were co-infected with ∆M-EGFP and ∆F-mSB at a multiplicity of infection (MOI) of 28 
0.1, complemented viruses were easily obtained. Complemented viruses grew as 29 
efficiently as wild-type BPIV3 and could be passaged in MDBK cell cultures even at 30 
an MOI of 0.01, possibly due to multiploid virus particles containing genomes of both 31 
∆M-EGFP and ∆F-mSB. This reciprocal complementation method using two defective 32 
viruses would be useful to express large or multiple proteins in cell cultures using 33 
paramyxovirus vectors. 34 
 35 
1. Introduction 36 
Bovine parainfluenza virus type 3 (BPIV3), a member of the genus Respirovirus in the 37 
family Paramyxoviridae in the order Mononegavirales, is an enveloped virus with a 38 
non-segmented negative-sense RNA genome (Karron and Collins, 2013). The BPIV3 39 
genome encodes six structural proteins: nucleocapsid (N), phospho (P), matrix (M), 40 
fusion (F), hemagglutinin-neuraminidase (HN) and large (L) proteins. The M protein is 41 
a nonintegral, membrane-associated protein localizing under the lipid bilayer of virus 42 
particles. The M protein is a key driver of virus particle formation. The F protein is an 43 
integral membrane protein on virus particles and essential for virus-cell fusion (Karron 44 
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and Collins, 2013). 45 
  Reverse genetics systems of Mononegavirales were first achieved for rabies virus in 46 
1994 (Schnell et al., 1994). Since then, many reverse genetics systems have been 47 
established for Mononegavirales, and generated recombinant viruses were utilized to 48 
study the function of viral proteins or viral genome sequences. Reverse genetics 49 
systems of Mononegavirales have also been used to generate novel vaccines 50 
expressing foreign proteins as antigens (Le Bayon et al., 2013; Sato et al., 2011) or 51 
novel medicines such as oncolytic viruses (Pfaller et al., 2015). Recently, recombinant 52 
paramyxoviruses are used to establish induced pluripotent stem (iPS) cells (Ban et al., 53 
2011; Nishimura et al., 2011). However, the insertion of multiple or long transcription 54 
cassettes of foreign genes into paramyxovirus genomes could reduce viral growth 55 
(Bukreyev et al., 2006). To increase the capacity of paramyxovirus vectors to carry 56 
multiple or long extra gene units, paramyxoviruses containing segmented genomes 57 
were generated (Gao et al., 2008; Takeda et al., 2006).  58 
    In this study, we generated two defective BPIV3 strains, one lacking the M 59 
protein gene and the other lacking the F protein gene, to increase the capacity of 60 
BPIV3 vectors and propagated them by co-infection.   61 
 62 
2. Materials and methods 63 
2.1. Cells and viruses 64 
MDBK, HeLa and Vero monolayer cell cultures were maintained in Dulbecco’s 65 
modified essential medium (DMEM) supplemented with 10% fetal bovine serum 66 
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(FBS), 100 units/ml of penicillin G and 100 µg/ml of streptomycin. The modified 67 
vaccinia virus Ankara (MVA-T7), which expresses the phage T7 RNA polymerase 68 
(Wyatt et al., 1995), was grown in chicken embryonic fibroblasts.   69 
 70 
2.2. Cloning of the M and F genes of BPIV3 into a pCAGGS plasmid vector 71 
To construct the M-expressing plasmid, the open reading frame of the M gene was 72 
synthesized from p(+)BPIV3-EGFP (Ohkura et al., 2015) by PCR using the primers 73 
5'-CGCGCTCGAGATGAGCATTACCAACTCTGC-3' (XhoI site is underlined) and 74 
5'-CGCGCGATATCTTACTGTCTGATTTTCCCGA-3' (EcoRV site is underlined) and 75 
ligated between XhoI and EcoRV sites of the pCAGGS plasmid (Niwa et al., 1991), 76 
resulting in pCAGGS-M. To construct the F-expressing plasmid, the open reading 77 
frame of the F gene was synthesized from p(+)BPIV3-EGFP (Ohkura et al., 2015) by 78 
PCR using the primers 5'-GCGCCTCGAGCATGATCATCACAAACACAAT-3' (XhoI 79 
site is underlined) and 5'-GCGCGGATATCTCATTGTCTACTTGTTAGTA-3' (EcoRV 80 
site is underlined) and ligated between XhoI and EcoRV sites of pCAGGS plasmid, 81 
resulting in pCAGGS-F.  82 
 83 
2.3. Construction of BPIV3 cDNA deficient of either the M or F gene 84 
To construct BPIV3 cDNA deficient of the M gene, two fragments were synthesized 85 
from p(+)BPIV3-EGFP by PCR. The first fragment covering the XhoI site in the P 86 
gene to the noncoding region between the gene start sequence for the M gene and M 87 
gene open reading frame was amplified using primers 88 
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5'-GCAGCTCAGATAGTAGAGCT-3' and 89 
5'-GCGAAGCTTCGGAGGATGGATTGATACTT-3' (HindIII site is underlined) and 90 
digested with XhoI and HindIII. The second fragment covering the noncoding region 91 
between the gene start sequence for the F gene and F gene open reading frame and the 92 
NheI site in the HN gene was amplified using primers 93 
5'-GCGAAGCTTCCAATACATAGATCACAGGA-3' (HindIII site is underlined) and 94 
5'-GCGGCTAGCCTGATTGCAGTCTCTCTGTG-3' (NheI site is underlined) and 95 
digested with HindIII and NheI. The two PCR fragments were then ligated between 96 
XhoI and NheI sites of p(+)BPIV3-EGFP, resulting in p(+)BPIV3∆M-EGFP. To 97 
construct BPIV3 cDNA deficient of the F gene, two fragments were synthesized from 98 
p(+)BPIV3-EGFP by PCR. The first fragment covering the XhoI site in the P gene to 99 
the noncoding region between the gene start sequence for the F gene and F gene open 100 
reading frame was amplified using primers 5'-GCAGCTCAGATAGTAGAGCT-3' and 101 
5'-GCGAAGCTTTAACTGTTGCTCGGAGTTTG-3' (HindIII site is underlined) and 102 
digested with XhoI and HindIII. The second fragment covering the noncoding region 103 
between the gene start sequence for the HN gene and HN gene open reading frame and 104 
the NheI site in the HN gene was amplified using primers 105 
5'-CGGAAGCTTAGAGACGACACCAAATTCAA-3' (HindIII site is underlined) and 106 
5'-GCGGCTAGCCTGATTGCAGTCTCTCTGTG-3' (NheI site is underlined) and 107 
digested with HindIII and NheI. The two PCR fragments were then ligated between 108 
XhoI and NheI sites of p(+)BPIV3-EGFP, resulting in p(+)BPIV3∆F-EGFP. The 109 
mStrawberry (mSB) gene was synthesized from pmStrawberry (Clontech, Mountain 110 
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View, CA) by PCR using primers 111 
5'-CCCGTCGACCACCATGGTGAGCAAGGGCGAG-3' (SalI site is underlined) and 112 
5'-CCCACGCGTTTACTTGTACAGCTCGTCCATGCC-3' (MluI site is underlined) 113 
and digested with SalI and MluI. The EGFP gene in p(+)BPIV3∆F-EGFP was removed 114 
by digesting with SalI and MluI and replaced with the mSB gene digested with SalI 115 
and MluI, resulting in p(+)BPIV3∆F-mSB.  All plasmids were prepared in Stbl2 cells 116 
(Life Technologies, Grand Island, NY) at 30˚C. 117 
 118 
2.4. Rescue of infectious viruses from p(+)BPIV3∆M-EGFP or p(+)BPIV3∆F-mSB 119 
plasmids 120 
HeLa cells in a 6-well plate (80% confluent) were infected with vaccinia virus 121 
MVA-T7 at an MOI of 1. One hour post-infection, the p(+)BPIV3∆M-EGFP or 122 
p(+)BPIV3∆F-mSB plasmid (4 µg) was transfected into the MVA-T7-infected HeLa 123 
cells together with pCAGGS-M or pCAGGS-F in addition to supporting plasmids 124 
(pGEM-N, pGEM-P and pGEM-L) in the presence of 10 µl of Lipofectamine 2000 125 
(Life Technologies) in 250 µl of Opti-MEM (Life Technologies). After 6 hours 126 
incubation, media were replaced with DMEM supplemented with 10% FBS and 127 
antibiotics. Three days post-transfection, the supernatants of p(+)BPIV3∆M-EGFP- or 128 
p(+)BPIV3∆F-mSB-transfected cells were harvested and transferred onto Vero cells 129 
transfected with pCAGGS-M or pCAGGS-F, respectively. After incubation for 3 days, 130 
rBPIV3∆M-EGFP or rBPIV3∆F-mSB were recovered from p(+)BPIV3∆M-EGFP- or 131 
p(+)BPIV3∆F-mSB-transfected cells, respectively. 132 
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 133 
2.5. Reciprocal complementation between M- and F-deficient BPIV3 strains 134 
Monolayer cultures of MDBK cells in 6-well cluster plates were infected with 135 
rBPIV3∆M-EGFP and rBPIV3∆F-mSB at an MOI of 0.1 50% tissue culture infective 136 
dose (TCID50)/cell and incubated at 37˚C for 3 days. 137 
 138 
2.6. Microscopic detection of EGFP and mSB fluorescence 139 
EGFP and mSB fluorescence in infected cells was photographed using a fluorescence 140 
microscope (TS100, Nikon, Tokyo, Japan) equipped with a charge-coupled device 141 
(CCD) camera (DS-Fi1, Nikon).  142 
 143 
2.7. Growth curves 144 
Monolayer cultures of MDBK cells in 24-well cluster plates were infected with the 145 
rBPIV3∆M-EGFP, rBPIV3∆F-mSB or reciprocally complemented viruses and 146 
incubated at 37˚C. At various time points, media were harvested and the infectious titer 147 
was determined by the TCID50 in MDBK cells under a fluorescent microscope. 148 
 149 
2.8. Western blotting 150 
Cells were lysed in SDS loading buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl) and 151 
were disrupted by sonication for 10 min. After centrifugation, the lysates were 152 
electrophoresed in 10% sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE). 153 
The proteins in the gel were transferred to a polyvinylidene difluoride membrane 154 
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(Millipore, Bedford, Mass). M and F proteins were detected using rabbit sera against 155 
synthetic peptides corresponding to the M protein (CRSKDRYGSVSDLDDDPS) and 156 
the F protein (IQGKNQNDKNSEPYVLTSRQ), respectively. 157 
 158 
2.9. Recover of viruses from plaques  159 
Viruses in plaques were recovered with agarose gel overlay using sterilized Pasteur 160 
pipets under a fluorescent microscope and were suspended in the medium. After brief 161 
centrifugation, viruses were inoculated into MDBK cells. 162 
 163 
3. Results 164 
3.1. Generation of an M or F gene-deficient BPIV3 strain 165 
To construct M or F gene-deficient infectious BPIV3 cDNA, the M or F gene was 166 
deleted from p(+)BPIV3-EGFP (Ohkura et al., 2015) using mutant primers and 167 
RT-PCR, resulting in the generation of p(+)BPIV3∆M-EGFP or the 168 
p(+)BPIV3∆F-EGFP, respectively. To discriminate M- and F-deficient viruses, the 169 
EGFP gene of p(+)BPIV3∆F-EGFP was replaced with mSB gene, resulting in 170 
p(+)BPIV3∆F-mSB (Fig. 1A). The M-deficient virus (∆M-EGFP) and the F-deficient 171 
virus (∆F-mSB) were recovered from p(+)BPIV3∆M-EGFP and p(+)BPIV3∆F-mSB 172 
using reverse genetics for BPIV3 (Ohkura et al., 2015) by supplying the M protein 173 
from pCAGGS-M plasmid or the F protein from pCAGGS-F plasmid, respectively. 174 
∆M-EGFP and ∆F-mSB were propagated in Vero cells transfected with pCAGGS-M 175 
and pCAGGS-F, respectively. Immunofluorescence assay and western blotting 176 
  9 
confirmed that ∆M-EGFP and ∆F-mSB expressed EGFP and mSB, respectively (Fig. 177 
1B), and not M protein and F protein, in infected MDBK cells (Fig. 1C). Interestingly, 178 
∆M-EGFP occasionally induced EGFP-expressing satellite cells at late stage (Fig. 1B). 179 
∆M-EGFP may have enhanced cell-cell fusion activity as reported for other M-less 180 
paramyxoviruses (Cathomen et al., 1998). 181 
 182 
3.2. Generation of complemented viruses 183 
When MDBK cells were singly infected with ∆M-EGFP or ∆F-mSB at a multiplicity 184 
of infection (MOI) of 0.1, infectious virus was not detected in culture supernatant as 185 
expected (Fig. 2A). However, when MDBK cells were co-infected with ∆M-EGFP and 186 
∆F-mSB at an MOI of 0.1, large amounts of infectious viruses expressing EGFP or 187 
mSB were produced in the culture supernatant, and EGFP and mSB fluorescence was 188 
observed throughout the entire area of culture dishes at day 3 post-infection (Fig. 2B). 189 
In contrast, at an MOI of 0.01, EGFP and mSB fluorescence did not spread even at day 190 
3 post-infection. These results suggest that when cells were co-infected with ∆M-EGFP 191 
and ∆F-mSB, the F and M proteins reciprocally complemented the growth of 192 
∆M-EGFP and ∆F-mSB in infected cells.  193 
 194 
3.3. Complemented viruses contain multiploid virus particles containing genomes of 195 
both ∆M-EGFP and ∆F-mSB  196 
To analyze the nature of complemented viruses, MDBK cells were infected with 197 
complemented viruses and overlaid with agarose containing culture medium. When 198 
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infected cells were observed under a fluorescent microscope at 2 days post-infection, 199 
three types of infected cells were observed; isolated single cells expressing EGFP, 200 
isolated single cells expressing mSB and plaques expressing both EGFP and mSB. 201 
Plaques co-expressing EGFP and mSB were observed at low MOI, suggesting that 202 
these plaques were induced by infection of multiploid virus particles containing 203 
genomes of both ∆M-EGFP and ∆F-mSB. Approximately one-quarter of 204 
complemented virus particles were multiploid virus particles containing genomes of 205 
both ∆M-EGFP and ∆F-mSB (Table 1). To rule out the possibility that these plaques 206 
were induced by recombinant viruses between ∆M-EGFP and ∆F-mSB, viruses in 207 
plaques were recovered and inoculated into MDBK cells. Again, isolated single cells 208 
expressing EGFP or mSB and cells expressing both EGFP and mSB were observed 209 
(Fig. 3A), indicating that plaques were induced by multiploid virus particles containing 210 
genomes of both ∆M-EGFP and ∆F-mSB. Complemented viruses spread efficiently in 211 
culture dishes even at an MOI of 0.001 (Fig. 3B) and grew as efficiently as wild-type 212 
virus (Ohkura et al., 2015) (Fig. 3C). The EGFP and mSB fluorescence were stable, 213 
and the ratio of ∆M-EGFP and ∆F-mSB was not changed during passages (data not 214 
shown).  215 
 216 
4. Discussion 217 
In this study, we generated two defective BPIV3 strains deficient for either the M or F 218 
gene and found that these BPIV3 strains could be easily rescued and propagated by 219 
co-infection. As each defective virus absolutely requires another defective virus to 220 
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replicate, extra genes inserted in both defective virus genomes could be maintained in 221 
successive culture. In paramyxovirus vectors, the addition of several extra transcription 222 
units or longer transcriptional units into genomes usually reduces viral replication 223 
(Bukreyev et al., 2006). It is generally believed that short genomes replicate rapidly, 224 
and long genomes replicate slowly. In our system, the M or F gene was deleted from 225 
the BPIV3 genome, resulting in a 1,164 base or 1,902 base reduction in the total 226 
genome length of BPIV3, respectively. These reductions could expand the coding 227 
capacity of the BPIV3 vector. According to the polar effect of transcription in 228 
paramyxoviruses (Bukreyev et al., 2006), extra transcriptional units should be inserted 229 
in the 3'-proximal region of paramyxoviruses to obtain the highest expression level. 230 
According to this requirement, two extra transcriptional units can be inserted in the 231 
nearly 3'-proximal region between the N and P genes in our system. Another advantage 232 
of using deleted genomes was increased rescue efficiencies; more infectious viruses 233 
were recovered from deleted genomes compared to complete genomes (data not 234 
shown). 235 
  We found that complemented viruses produced plaques co-expressing EGFP and 236 
mSB (Fig. 3A and Table 1). Previous studies indicated that paramyxoviruses particles 237 
are pleomorphic and contain multiple genomes (Dahlberg and Simon, 1969; Goff et al., 238 
2012; Granoff, 1959; Hosaka et al., 1966; Loney et al., 2009; Lund et al., 1984; Rager 239 
et al., 2002; Terrier et al., 2009). Thus, it is reasonable that multiploid virus particles in 240 
our complemented viruses contributed to the efficient spread of viruses in cell culture. 241 
We found that 23% of complemented viruses produced plaques co-expressing EGFP 242 
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and mSB. This frequency agrees with previous results obtained for Newcastle disease 243 
virus (NDV) (Goff et al., 2012), which showed that approximately 25% of NDV 244 
particles were multiploid.  245 
  Although several groups reported natural recombination between NDV strains 246 
(Chong et al., 2010; Han et al., 2008; Qin et al., 2008; Satharasinghe et al., 2016), there 247 
was no evidence of recombination between ∆M-EGFP and ∆F-mSB (Fig. 3A). These 248 
results agree with previous results obtained for human respiratory syncytial virus 249 
(RSV) (Spann et al., 2003), which showed that genetic recombination between two 250 
RSV strains was an extremely rare event. 251 
  In our system, multiploid virus particles are constantly generated and maintained in 252 
cell culture in contrast to the vesicular stomatitis virus system (Chattopadhyay and 253 
Rose, 2011), and there is a possibility that multiploid virus particles might be generated 254 
in vivo.  255 
  In summary, we found that two paramyxovirus strains deficient for different genes 256 
could be easily rescued by co-infection. This complementation method using two 257 
defective viruses may be useful to express large or multiple proteins in cell cultures. 258 
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Figure legends  372 
Fig. 1. Construction of the BPIV3 strains deficient in either the M or F gene 373 
(A) Schematic diagram of the genomic organization of wt-EGFP, ∆M-EGFP and 374 
  18 
∆F-mSB. (B) MDBK cells were infected with wt-EGFP, ∆M-EGFP or ∆F-mSB at an 375 
MOI of 0.01. Infected cells were visualized with autofluorescence of EGFP or mSB 376 
without fixation. (C) MDBK cells were infected with ∆M-EGFP, ∆F-mSB or 377 
uninfected. At day 2 post-infection, cells were lysed in SDS loading buffer and 378 
subjected to SDS-PAGE. M and F proteins were detected using rabbit sera against 379 
synthetic peptides corresponding to the M protein and the F protein, respectively. The 380 
asterisk in the left panel may be the F1 protein trimer. The asterisk in the right panel 381 
indicates nonspecific signal. 382 
 383 
Fig. 2. Recovery of complemented viruses  384 
(A) Replication kinetics of ∆M-EGFP (triangles), ∆F-mSB (squares) and the mixture 385 
of ∆M-EGFP and ∆F-mSB (circles). MDBK cells were infected with ∆M-EGFP or 386 
∆F-mSB at an MOI of 0.1 or infected with the mixture of ∆M-EGFP and ∆F-mSB at 387 
an MOI of 0.1 for each virus. Media were harvested at 0, 12, 24, 36, 48, 60 and 72 h 388 
post-infection, and infectious titers were assessed as TCID50 using MDBK cells. Data 389 
are presented as the mean ± standard deviations of triplicate samples. (B) MDBK cells 390 
were co-infected with ∆M-EGFP and ∆F-mSB at an MOI of 0.1 and 0.01. Infected 391 
cells were visualized with autofluorescence of EGFP or mSB at days 1 and 3 392 
post-infection. Photomicrographs of EGFP and mSB fluorescence were merged.  393 
 394 
Fig. 3. Growth and spread of complemented viruses in MDBK cells.  395 
(A) Isolation of viruses from a plaque. MDBK cells were infected with complemented 396 
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viruses at an MOI of 0.01 and overlaid with agarose. Plaques expressing both EGFP 397 
and mSB were observed using a fluorescent microscope. Viruses in a plaque were 398 
recovered from agarose and inoculated into MDBK cells. Infected cells were 399 
visualized with autofluorescence of EGFP and mSB at day 1 post-infection. 400 
Photomicrographs of EGFP and mSB fluorescence were merged. The white arrow 401 
indicates cells expressing both EGFP and mSB. (B) Spread of complemented viruses in 402 
MDBK cells. MDBK cells were infected with complemented viruses at an MOI of 0.1, 403 
0.01 and 0.001. Infected cells were visualized with autofluorescence of EGFP or mSB 404 
at days 1 and 3 post-infection. Photomicrographs of EGFP and mSB fluorescence were 405 
merged. (C) Replication kinetics of complemented viruses in MDBK cells. MDBK 406 
cells were infected with complemented viruses at an MOI of 0.1 and 0.01. Media were 407 
harvested at 0, 12, 24, 36, 48, 60 and 72 h post-infection, and infectious titers were 408 
assessed as TCID50 using MDBK cells. 409 
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